About Solventum Corporation (SOLV)
Solventum Corporation is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Eagan, United States. SOLV has been publicly traded since 2024, giving it 2+ years of trading history.
Solventum Corporation (SOLV) has been publicly traded since 2024, making it a 2-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in Eagan, United States and employs approximately 20,584 people. With a market capitalization of $12 billion, SOLV is a large established company.
SOLV trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap-cap stock with a market capitalization of approximately $12 billion. The company employs approximately 20,584 people worldwide.
Key Statistics
- Current Price
- $66.76
- Market Cap
- $11.58B
- 52-Week High
- $88.20
- 52-Week Low
- $60.70
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
SOLV Investment Performance
SOLV has declined 15.8% year-to-date in 2026. Since its IPO in 2024, a $1,000 investment would now be worth $1,011.
$1,000 Invested in Solventum Corporation (SOLV)
How much would $1,000 invested in SOLV be worth today?
What would $1,000 invested in SOLV 1 year ago be worth today?
A $1,000 investment in Solventum Corporation (SOLV) in 2025 would be worth $1,011 as of May 2026, representing a +1.1% total return.
What would $1,000 invested in SOLV at IPO be worth today?
A $1,000 investment in Solventum Corporation (SOLV) at IPO would be worth $1,011 as of May 2026, representing a +1.1% total return.
Monthly Returns Heatmap
Over the past 2+ years (24 months), Solventum Corporation (SOLV) has averaged a monthly return of +0.21% with a median return of -2.17%. The stock had 10 positive months (42%) and 14 negative months (58%). The best month in SOLV's history was November 2025 with a +23.5% return, while the worst was April 2025 at -13.1%. Historically, November tends to be the strongest month (averaging +11.0%), and April the weakest (-9.8%).
SOLV's longest winning streak was 4 consecutive months of gains, while its longest losing streak was 4 consecutive months of losses. The best full year was 2025 with a cumulative return of +23.8%, and the worst was 2025 at 23.8%.
Annual Returns
Over 2 years of trading history, Solventum Corporation (SOLV) has delivered an average annual return of +2.10% with a median return of +2.10%. The compound annual growth rate (CAGR) is +0.53%. The stock posted gains in 1 years (50%) and losses in 1 years (50%).
SOLV's best year was 2025 with a +19.95% gain, while the worst was 2026 at -15.75%. The longest streak of consecutive positive years was 1, and the longest losing streak was 1 years. SOLV achieved double-digit gains (10%+) in 1 years. It suffered double-digit losses in 1 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -15.75% | $79.24 | $66.76 |
| 2025 | +19.95% | $66.06 | $79.24 |
SOLV Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Solventum Corporation as an investment
Valuation
SOLV currently trades at a trailing P/E ratio of 7.5, which is considered low relative to the broader market. The forward P/E of 9.4 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 2.3. The price-to-sales ratio is 1.4.
Dividends
Solventum Corporation does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
The stock's 52-week range is $60.70 to $88.20, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 12 analyst opinions, SOLV has a consensus "buy" rating. The average price target of $90.17 suggests 35.1% upside from current levels.
Frequently Asked Questions: SOLV
What sector is SOLV in? ▼
SOLV operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has SOLV performed historically? ▼
Over 2 years of trading history, SOLV has posted gains in 1 years (50% of the time). The best year was 2025 with a +19.9% return. Past performance does not guarantee future results.
How can I invest in SOLV? ▼
You can invest in SOLV through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold SOLV.
Does SOLV pay dividends? ▼
Solventum Corporation does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
What does Solventum Corporation do? ▼
Solventum Corporation is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Eagan, United States.
What sector is SOLV in? ▼
SOLV operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
When did SOLV go public? ▼
Solventum Corporation went public in 2024, making it a 2-year-old public company as of 2026.
How much would $1,000 invested in SOLV at IPO be worth today? ▼
If you invested $1,000 in SOLV at its IPO in 2024, it would be worth approximately $1,011 today, a 1.1% return over 2 years.
Does SOLV pay dividends? ▼
No, Solventum Corporation does not currently pay a dividend. The company reinvests its earnings into growth.
What is SOLV's market cap? ▼
Solventum Corporation has a market capitalization of $12 billion, classifying it as a large-cap company.
What is SOLV's P/E ratio? ▼
SOLV has a trailing P/E ratio of 7.5 and a forward P/E of 9.4, which measures how much investors are paying per dollar of earnings.
Is SOLV a buy, hold, or sell? ▼
Based on 12 opinions, SOLV has a consensus "buy" rating. The average price target is $90.17.
Last updated: 3/15/2026